In a new study, researchers developed a gene expression predictor that can indicate whether melanoma in a specific patient is likely to respond to treatment with immune checkpoint inhibitors, a novel type of immunotherapy. The predictor was developed by Noam Auslander, Ph.D., with other researchers in the Center for Cancer Research (CCR) at the National Cancer Institute (NCI), part of the National Institutes of Health, and colleagues at Harvard University, Cambridge, Massachusetts; the University of Pennsylvania, Philadelphia; and the University of Maryland, College Park. The study was published Aug. 20, 2018 in Nature Medicine.

Related posts:

  1. Medicare Card, NCI study identifies essential genes for cancer immunotherapy Medicare Card, NCI study identifies essential genes for cancer immunotherapy...
  2. Medicare Card, Investigational malaria vaccine protects healthy U.S. adults for more than one year Medicare Card, Investigational malaria vaccine protects healthy U.S. adults for more than one year...
  3. Medicare Card, Social interaction affects cancer patients’ response to treatment Medicare Card, Social interaction affects cancer patients’ response to treatment...
  4. Medicare Card, NIH study demonstrates that a new cancer immunotherapy method could be effective against a wide range of cancers A new method for using immunotherapy to specifically attack tumor cells that have mutations unique to a patient’s cancer has been developed by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health. The researchers demonstrated that the human immune system can mount a response against mutant proteins expressed by cancers […]...
  5. Medicare Card, Strengthening the immune system’s fight against brain cancer Medicare Card, Strengthening the immune system’s fight against brain cancer...
  6. Medicare Card, Increased physical activity associated with lower risk of 13 types of cancer Medicare Card, Increased physical activity associated with lower risk of 13 types of cancer...
  7. Medicare Card, Uncovering a new principle in chemotherapy resistance in breast cancer Medicare Card, Uncovering a new principle in chemotherapy resistance in breast cancer...
  8. Medicare Card, Researchers find link between death of tumor-support cells and cancer metastasis Medicare Card, Researchers find link between death of tumor-support cells and cancer metastasis...
  9. Medicare Card, Elevated bladder cancer risk in New England and arsenic in drinking water from private wells Medicare Card, Elevated bladder cancer risk in New England and arsenic in drinking water from private wells...
  10. Medicare Card, Novel genetic mutation may lead to the progressive loss of motor function Medicare Card, Novel genetic mutation may lead to the progressive loss of motor function...
  11. Medicare, Medicare Card, Receptor Variant Influences, Dopamine Response to Alcohol A genetic variant of a receptor in the brain’s reward circuitry plays an important role in determining whether the neurotransmitter dopamine is released in the brain following alcohol intake, according to a study led by researchers at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health. Dopamine is […]...
  12. Medicare Card, NIAID scientists identify cause, possible treatment for life-threatening gut condition Medicare Card, NIAID scientists identify cause, possible treatment for life-threatening gut condition...
  13. Medicare, study uncovers new mechanism of action for class of chemotherapy drugs National Institutes of Health (NIH) researchers have discovered a significant new mechanism of action for a class of chemotherapy drugs known as poly (ADP-ribose) polymerase inhibitors, or PARP inhibitors. They have also identified differences in the toxic capabilities of three drugs in this class which are currently being tested in clinical trials. The study, by […]...
  14. Medicare Card, Study points to possible treatment for lethal pediatric brain cancer Medicare Card, Study points to possible treatment for lethal pediatric brain cancer...
  15. Medicare Card, Microchip captures clusters of circulating tumor cells Medicare Card, Microchip captures clusters of circulating tumor cells...